Pnc Financial Services Group, Inc. Cytokinetics Inc Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 6,049 shares of CYTK stock, worth $401,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,049
Previous 4,706
28.54%
Holding current value
$401,895
Previous $155,000
114.19%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding CYTK
# of Institutions
456Shares Held
128MCall Options Held
5.23MPut Options Held
1.18M-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.1MShares$1.27 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$800 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.41MShares$492 Million0.07% of portfolio
-
State Street Corp Boston, MA5.62MShares$373 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.25B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...